ADVANCED PROTEOME THERAPEUTICS CORPORATION

Otros idiomas Advanced Proteome Therapeutics Corporation

Acciones

APC.H

CA0076282098

Diferido Toronto S.E. Otros sitios de cotización 21:55:53 04/12/2023			Varia. Cinco días.	Varia. 1 de enero.
0,005 ^CAD	-.--%		-.--%	-.--%

2023	Advanced Proteome Therapeutics Corporation presenta los resultados del tercer trimestre y los nueve meses finalizados el 30 de abril de 2023	CI
2023	Advanced Proteome Therapeutics Corporation informa de los resultados del segundo trimestre y los seis meses finalizados el 31 de enero de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Canadian Investment Regulatory Organization Trading Halt - APC.H	05/12
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023	30/06/23
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023	29/03/23
IIROC Trading Resumption - APC	17/01/23
IIROC Trading Halt - APC	17/01/23
Advanced Proteome Therapeutics Corporation agreed to Spin-Off Linceis Capital Corp.	17/01/23
Advanced Proteome Therapeutics Corporation announced that it has received CAD 0.0725 million in funding from Conation Capital	23/12/22
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the First Quarter Ended October 31, 2022	21/12/22
Advanced Proteome Therapeutics Corporation Appoints Mr. Cory Brandolini to the Board of Directors	21/11/22
Advanced Proteome Therapeutics Corporation Auditor Raises 'Going Concern' Doubt	15/11/22
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Full Year Ended July 31, 2022	15/11/22
ADVANCED PROTEOME THERAPEUTICS RECEIVES ISSUED PATENT	04/08/22
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2022	28/06/22
Advanced Proteome Therapeutics up 28.5%, Receives Notice of Allowance for Patent Claims	13/04/22
Advanced Proteome Therapeutics Receives Notice of Allowance for Patent Claims	13/04/22
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2022	25/03/22
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the First Quarter Ended October 31, 2021	17/12/21
Advanced Proteome Therapeutics Corporation Auditor Raises 'Going Concern' Doubt	29/11/21
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Full Year Ended July 31, 2021	29/11/21
Advanced Proteome Therapeutics Provides Update on COVID Program	24/08/21

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Advanced Proteome Therapeutics Corporation

Acciones

APC.H

CA0076282098

Otros idiomas

Filtros